New hope for High-Risk pregnancies: can a common drug save tiny babies?
NCT ID NCT07462182
Summary
This study is testing if adding a blood-thinning medication called enoxaparin to standard care can improve outcomes for babies who are growing too slowly in the womb and have low amniotic fluid. It will involve 108 pregnant women in Pakistan. Researchers will compare the number of live births and baby weights between those who receive the drug and those who receive standard care alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAUTERINE GROWTH RESTRICTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Combined Military Hospital
Quetta, Balochistan, 80000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.